K2 Principal Fund’s Bausch Health BHC Stock Holding History

K2 Principal Fund’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-83,238	Closed	-$2.03M	–	307
2021 Q4	$2.3M	Buy	+83,238	New	+$2.23M	0.15%	125
2021 Q3	–	Sell	-11,200	Closed	-$318K	–	319
2021 Q2	$328K	Buy	+11,200	New	+$339K	0.03%	289
2020 Q4	–	Sell	-143,271	Closed	-$2.67M	–	317
2020 Q3	$2.23M	Buy	+143,271	New	+$2.47M	0.33%	102

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

K2 Principal Fund's BHC Position: Q1 2022 in Review

K2 Principal Fund sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 83,238 shares — an estimated $2.03M sold.

K2 Principal Fund first reported a position in BHC in Q3 2020 and held it in 3 quarters. The position peaked at $2.3M in Q4 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

K2 Principal Fund reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
K2 Principal Fund sold 83,238 Bausch Health shares in Q1 2022, an estimated $2.03M.
K2 Principal Fund first reported a position in Bausch Health in Q3 2020 and held it in 3 quarters.
K2 Principal Fund's Bausch Health position peaked at $2.3M in Q4 2021.
370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on K2 Principal Fund's 13F filing for Q1 2022, filed 16 May 2022.